{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T13:30:07Z","timestamp":1649079007061},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.intimp.2007.09.005","type":"journal-article","created":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T18:06:25Z","timestamp":1191261985000},"page":"267-270","source":"Crossref","is-referenced-by-count":1,"title":["Protective actions of human tissue kallikrein gene in transgenic rat hearts"],"prefix":"10.1016","volume":"8","author":[{"suffix":"Jr.","given":"J.A.","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.B.","family":"Pesquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2007.09.005_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ncpneph0444","article-title":"Mechanisms of disease: the tissue KKS in hypertension and vascular remodeling","volume":"3","author":"Madeddu","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.intimp.2007.09.005_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0162-3109(96)00061-6","article-title":"Kinins in the cardiovascular system","volume":"33","author":"Sch\u00f6lkens","year":"1996","journal-title":"Immunopharmacology"},{"issue":"2","key":"10.1016\/j.intimp.2007.09.005_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1515\/BC.2006.017","article-title":"Genetically altered animal models in the kallikrein-kinin system","volume":"387","author":"Pesquero","year":"2006","journal-title":"Biol Chem"},{"issue":"13","key":"10.1016\/j.intimp.2007.09.005_bib4","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1096\/fj.99-1010fje","article-title":"Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene","volume":"14","author":"Silva","year":"2000","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.intimp.2007.09.005_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1515\/BC.2006.085","article-title":"The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction","volume":"387","author":"Chao","year":"2006","journal-title":"Biol Chem"},{"issue":"1","key":"10.1016\/j.intimp.2007.09.005_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/cs0840061","article-title":"Regulation of beta myosin heavy chain, c-myc and c-fos proto-oncogenes in thyroid hormone-induced hypertrophy of the rat myocardium","volume":"84","author":"Green","year":"1993","journal-title":"Clin Sci (Lond)"},{"issue":"1\u20133","key":"10.1016\/j.intimp.2007.09.005_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0303-7207(91)90216-F","article-title":"ATP, bradykinin, TRH and TSH activate the Ca(2+)-phosphatidylinositol cascade of human thyrocytes in primary culture","volume":"81","author":"Raspe","year":"1991","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.intimp.2007.09.005_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.CIR.83.1.13","article-title":"Cardiac hypertrophy. Mechanical, neural, and endocrine dependence","volume":"83","author":"Morgan","year":"1991","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.intimp.2007.09.005_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00424-006-0192-0","article-title":"AT1 and AT2 receptors mediate the increase in TGF-beta1 in thyroid hormone-induced cardiac hypertrophy","volume":"454","author":"Diniz","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.intimp.2007.09.005_bib10","doi-asserted-by":"crossref","first-page":"15073","DOI":"10.1074\/jbc.M207593200","article-title":"Triiodothyronine increases BNP gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes","volume":"278","author":"Liang","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.intimp.2007.09.005_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.14310\/horm.2002.1158","article-title":"Normalization of thyroid hormone levels in patients with either hyper-or hypothyroidism results in a profound change of atrial natriuretic peptide (ANP) levels","volume":"1","author":"Koukoulis","year":"2002","journal-title":"Hormones (Athena)"},{"issue":"2","key":"10.1016\/j.intimp.2007.09.005_bib12","first-page":"S119","article-title":"Plasma atrial natriuretic peptide values in cardiac disease","volume":"4","author":"Lang","year":"1986","journal-title":"J Hypertens, Suppl"},{"issue":"2","key":"10.1016\/j.intimp.2007.09.005_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1073\/pnas.85.2.339","article-title":"Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload","volume":"85","author":"Izumo","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2007.09.005_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1024153003249","article-title":"The expression of mRNA of cytokines and of extracellular matrix proteins in triiodothyronine-treated rat hearts","volume":"247","author":"Ziegelh\u00f6ffer-Mihalovicov\u00e1","year":"2003","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"10.1016\/j.intimp.2007.09.005_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.matbio.2006.12.005","article-title":"Thyroid hormone induces myocardial matrix degradation by activating matrix metalloproteinase-1","volume":"26","author":"Ghose Roy","year":"2007","journal-title":"Matrix Biology"},{"key":"10.1016\/j.intimp.2007.09.005_bib16","first-page":"25","article-title":"Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors","volume":"47","author":"Linz","year":"1995","journal-title":"Pharmacol Rev"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576907002895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576907002895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T12:45:34Z","timestamp":1556887534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576907002895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S1567576907002895"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2007.09.005","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}